Tea Intake, COMT Genotype, and Breast Cancer in Asian-American Women

Cancer Research

Volumn 63, Issue 21, 2003, Pages 7526-7529

  Wu, Anna H ^a,b   Tseng, Chiu Chen ^a   Van Den Berg, David ^a   Yu, Mimi C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; CATECHOL METHYLTRANSFERASE; NATURAL PRODUCT; POLYPHENOL DERIVATIVE;

ADULT; AGED; ALLELE; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COMT GENE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOOD INTAKE; GENE; GENE ACTIVITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PRIORITY JOURNAL; TEA; UNITED STATES;

ADULT; AGED; ALLELES; ASIAN AMERICANS; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; CHINA; FEMALE; GENOTYPE; HUMANS; JAPAN; MIDDLE AGED; PHILIPPINES; TEA; UNITED STATES;

EID: 0242442468     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Yang, C. S., Maliakal, P., and Meng, X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol., 42: 25-54, 2002.
2. Zhu, B. T., Patel, U. K., Cai. M. X., and Conney, A. H. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase. Drug Metab. Dispos., 28: 1024-1030, 2000.
3. Zhu, B. T. Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr. Drug Metab., 3: 321-349, 2002.
4. Weinshilboum, R. M., and Raymond, F. A. Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am. J. Hum. Genet., 29: 125-135, 1977.
5. Dawling, S., Noodi, N., Mernaugh, R. L., Wang, X., and Parl, F. F. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res., 61: 6716-6722. 2001.
6. Goodman, J. E., Jensen, L. T., He, P., and Yager, J. D. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Pharmacogenetics, 12: 517-528, 2002.
7. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
8. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S., Comstock, G. W., Yager, J. D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res., 15: 5493-5497, 1997.
9. Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F. F., and Ambrosone, C. B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res., 58, 2107-2110, 1998.
10. Millikan, R. C., Pittman, G. S., Tse, C. K. J., Duell, E., Newman, B., Savitz, D., Moorman, P. G., Boissy, R. J., and Bell, D. A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (Lond.), 19: 1943-1947, 1998.
11. Mitrunen, K., Jourenkova, N., Kataja, V., Eskelinen, M., Kosma, V. M., Benhamou, S., Kang, D., Vainio, H., Uusitupa, M., and Hirvonen, A. Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 635-640, 2001.
12. Goodman, J. E., Lavigne, J. A., Wu, K., Helzlsouer, K. J., Strickland, P. L., Selhub, J., and Yager, J. D. COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk. Carcinogenesis (Lond.), 22: 1661-1665, 2001.
13. Huang, C. S., Chern, H. D., Chang, K. J., Cheng, C. W., Hsu, S. M., and Shen, C. Y. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, COMT: a multigenic study on cancer susceptibility. Cancer Res., 59: 4870-4875, 1999.
14. 158Met polymorphism of catechol-O-methyl transferase and breast cancer. Pharmacogenetics, 11: 279-286, 2001.
15. Hamajima, N., Matsuo, K., Tajima, K., Mizutani, M., Iwata, H., Iwase, T., Miura. S., Oya, H., and Obata, Y. Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int. J. Clin. Oncol., 6, 13-18, 2001.
16. Bergman-Jungestrom, M., and Wingren. S. Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br. J. Cancer, 85: 859-862, 2001.
17. Kocabas, N. A., Sardas, S., Cholerton, S., Daly, A. K., and Karakaya, A. E. Cytochrome P450 CYP1B1 and catechol-O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population. Arch. Toxicol., 76: 643-649, 2002.
18. Wedren, S., Rudqvist, T. R., Granath, F., Weiderpass, E., Ingelman-Sundberg, M., Persson, I. and Magnusson, C. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk. Carcinogenesis (Lond.), 24: 681-687, 2003.
19. Wu, A. H., Yu, M. C., Tseng, C. C., Hankin, J., and Pike, M. C. Green tea and risk of breast cancer in Asian-Americans. Int. J. Cancer. 106: 574-579, 2003.
20. Wu. A. H., Wan, P., Hankin, J., Tseng, C. C., Yu, M. C., and Pike, M. C. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis (Lond.), 23: 1491-1496, 2002.
21. Pike, M. C., Peters, R. K., Cozen, W., Probst-Hensch, N. M., Felix, J. C., Wan, P. C., and Mack, T. M. Estrogen-progestin replacement therapy and endometrial cancer. J. Natl. Cancer Inst. (Bethesda), 89: 1110-1116, 1997.
22. Stram, D. O., Hankin, J. H., Wilkens, L. R., Pike, M. C., Monroe, K. R., Park, S., Henderson, B., Nomura, A. M. Y., Earle, M. E., Nagamine, F. S., and Kolonel, L. N. Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am. J. Epidemiol., 151: 358-370, 2000.
23. Yang, C. S., and Wang, Z. Y. Tea and cancer. J. Natl. Cancer Inst. (Bethesda), 85: 1038-1049, 1993.
24. Lee, L. G., Connell, C. R., and Bloch, W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucliec Acids Res., 21: 3761-3766, 1993.
25. Syvanen, A. C., Tilgmann, C., Rinne, J., and Ulmanen, I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics, 7: 65-71, 1997.
26. Kavanagh, K. T., Hafer, L. J., Kim, D. W., Mann, K. K., Sherr, D. H., Rogers, A. E., and Sonenshein, G. E. Green tea extracts decrease carcinogen-induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem., 82: 387-398, 2001.
27. Pianetti, S., Guo, S., Kavanagh, K. T., and Sonenshein, G. E. Green tea polyphenol epigallocatechin-E gallate inhibits Her-2/Neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res., 62: 652-655, 2002.
28. Rogers, A., Hafer, J. J., Iskander, V. S., and Yang, S. Black tea and mammary gland carcinogenesis by 7,12-dimethybenz[a]anthracene in rats fed control or high fat diets. Carcinogenesis (Lond.), 19: 1269-1273, 1998.
29. Zhu, B. T., and Conney, A. H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis (Lond.), 19: 1-27, 1998.